反应详情

rac-N2-(4-{4-Amino-1-[1-(2-methoxyethyl)tetrahydro-1H-3-pyrrolyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}phenyl)-7-isopropyl-1,3-benzoxazol-2-amine was prepared from rac-3-iodo-1-[1-(2-methoxyethyl)tetrahydro-1H-3-pyrrolyl]-1H-pyrazolo[3,4-d]pyrimidin-4-amine (0.200 g, 0.515 mmol) and N2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-7-isopropyl-1,3-benzoxazol-2-amine (0.244 g, 0.644 mmol) in a manner similar to that used for the preparation of cis-N2-(4-{4-amino-1-[4-(4-methylpiperazino)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-fluorophenyl)-1,3-benzoxazol-2-amine. The compound was formed as an off-white solid (0.067 g, 25%). 1H NMR (DMSO-d6, 400 MHz) 1.361 (d, 6H), 2.30 (m, 2H), 2.66 (m, 2H), 2.76-2.83 (m, 3H), 3.17 (t, 1H), 3.24 (s, 3H), 3.38 (m, 1H), 3.45 (t, 2H), 5.37 (m, 1H), 7.04 (d, 1H), 7.18 (t, 1H), 7.32 (d, 2H), 7.67 (d, 2H), 7.95 (d, 2H), 8.24 (s, 1H), 10.88 (s, 1H); RP-HPLC Rt 12.337 min, 94% purity (5% to 85% acetonitrile/0.1M aqueous ammonium acetate, buffered to pH 4.5, over 20 min at 1 mL/min; λ=254 nm; Deltapak C18, 300 Å, 5 μm, 150×3.9 mm column); m/z 513 (MH+).